New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 15, 2013
13:11 EDTHLF, NUS Nu Skin advances after Icahn reports stake in Herbalife
Multi-level marketer Nu Skin (NUS) is climbing after Carl Icahn reported last night that he had obtained a 13% stake in Herbalife (HLF), which is also a multi-level marketer. The target of a massive short selling campaign during the last several months by billionaire investor Bill Ackman, Herbalife sells nutritional supplements. Ackman has said that Herbalife is a Ponzi scheme that will ultimately fail. Meanwhile, Icahn stated in an SEC filing yesterday and on CNBC earlier today that Herbalife is undervalued. Icahn also contends Herbalife should examine the possibility of taking the company private. Neither Herbalife nor Nu Skin has been confirmed to be targeted by regulators recently, but the FTC on January 28 sued Kentucky based Fortune Hi-Tech for allegedly operating a pyramid scheme. Fortune Hi-Tech has been placed in receivership. In mid-afternoon trading, Nu Skin rose 1.5% to $42.55, while Herbalife was up 7.5% to $41.14.
News For NUS;HLF From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 1, 2015
15:43 EDTHLFHerbalife May volatility elevated into Q1 and outlook
Subscribe for More Information
10:03 EDTHLFHerbalife products stockpiled in Mexico, Seeking Alpha contributor says
Subscribe for More Information
April 28, 2015
10:19 EDTHLFPershing Square lists Herbalife, Actavis as top Q1 losers
Subscribe for More Information
April 27, 2015
05:47 EDTHLFStocks with implied volatility movement; HLF ALTR
Subscribe for More Information
April 23, 2015
11:08 EDTHLFHerbalife confirms to Bloomberg 2% price increase in U.S.
Subscribe for More Information
07:41 EDTHLFHerbalife price target raised to $50 from $42 at Canaccord
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use